Cooperative Agreement U01FD008732
- Federal Cooperative Agreement Summary The University of Kentucky Research Foundation received a $224,999 Cooperative Agreement award from the Food and Drug Administration (FDA) Research program (CFDA 93.103) on September 20, 2025, with performance extending through June 30, 2026. The University of Kentucky Division of Regulatory Services (UKDRS) will deliver comprehensive animal feed regulatory program services aligned with Animal Feed Regulatory Program Standards (AFRPS) in partnership with the...
- Summary of Federal Cooperative Agreement Award The Kentucky Department for Public Health, Division of Laboratory Services (DLS), received a $150,000 Cooperative Agreement from the Food and Drug Administration (FDA) under the Food and Drug Administration Research program (CFDA 93.103), awarded September 20, 2025, with completion targeted for June 30, 2030. This award supports the KY DPH-DLS Environmental & Food Surveillance Testing initiative, which enhances Kentucky's capacity to conduct...
- Federal Cooperative Agreement Award Summary The University of Illinois received a $199,500 Cooperative Agreement award from the Food and Drug Administration (FDA) under the FDA Research program (CFDA 93.103), effective September 20, 2025, through August 31, 2030. This award supports the National Antimicrobial Resistance Monitoring System (NARMS) Retail Food Surveillance Program in Illinois, which provides standardized microbiological testing and analysis of retail meat and seafood products to...
- Federal Cooperative Agreement Summary The University of Puerto Rico, Estacion Experimental Agricola received a $380,000 Cooperative Agreement from the Food and Drug Administration's Center for Veterinary Medicine under the Food and Drug Administration Research program (CFDA 93.103), awarded September 20, 2025, with completion targeted for August 31, 2030. The award funds the "Surveillance and Genomic Characterization of Antimicrobial Resistance in Puerto Rico's Retail Food" program,...
- Federal Cooperative Agreement Summary The Food and Drug Administration (FDA) awarded a Cooperative Agreement valued at $435,000 to the North Carolina Department of Agriculture & Consumer Services (NCDA&CS) under the FDA Research program (CFDA 93.103), effective September 25, 2025, with completion targeted for June 30, 2030. Through this award, the Food and Drug Protection Division (FDPD) will enhance human food testing capabilities and support a nationally integrated,...
- Federal Cooperative Agreement Summary Penn State University received a $110,000 Cooperative Agreement from the Food and Drug Administration (FDA) Research program (CFDA 93.103) on September 20, 2025, to support wastewater-based microbial genomics research for enhanced surveillance of foodborne pathogens through June 30, 2030. Under this five-year partnership with the Pennsylvania Department of Health, the awardee will continue generating whole genome sequencing (WGS) sequences of foodborne...
- Federal Cooperative Agreement Summary The Food and Drug Administration (FDA), through its Food and Drug Administration Research program (CFDA 93.103), awarded $590,000 to the Tennessee Department of Agriculture's Division of Animal Industries on September 20, 2025, with a completion date of June 30, 2030. This Cooperative Agreement supports the enhancement of Tennessee's human and animal food testing laboratory capacity to strengthen an Integrated Food Safety System (IFSS) aligned with the...
- Federal Cooperative Agreement Summary The Food and Drug Administration (FDA) Research program (CFDA 93.103) awarded the Regents of the University of Minnesota a Cooperative Agreement valued at $199,999 on September 20, 2025, to advance antimicrobial use (AU) measurement in U.S. companion animal veterinary practice through September 2030. The project leverages the Companion Animal Veterinary Surveillance Network (CAVSNET), a public-private partnership that standardizes prescribing data from...
- Federal Cooperative Agreement Summary Health Research, Inc.'s Wadsworth Center Division has been awarded $480,000 under a Cooperative Agreement with the Food and Drug Administration (FDA) Research program (CFDA 93.103), effective September 25, 2025, through June 30, 2030. This award supports the continuation of an integrated food defense testing and method development program serving the FDA's Food Emergency Response Network (FERN). The Wadsworth Center will provide radiochemical,...
- Cooperative Agreement Summary The Food and Drug Administration (FDA) Office of Regulatory Affairs awarded a Cooperative Agreement totaling $535,954 to the National Association of State Departments of Agriculture Research Foundation (NASDA Foundation) on September 20, 2025, under the FDA Research program (CFDA 93.103). In collaboration with the Association of American Feed Control Officials (AAFCO), NASDA Foundation will deliver integrated animal food safety regulatory services through...
The University of Kentucky Research Foundation received a $399,992 Cooperative Agreement award from the Food and Drug Administration (FDA) under the FDA Research program (CFDA 93.103), effective September 20, 2025 through August 31, 2030. This cooperative agreement supports the Strengthening Antimicrobial Resistance Surveillance in Retail Food Commodities in Kentucky project, a collaborative effort with the FDA's Center for Veterinary Medicine to address the growing public health concern of antimicrobial-resistant (AMR) infections through retail food monitoring. Under this award, the Research Foundation will deliver comprehensive antimicrobial resistance surveillance products and services focused on retail meat commodities across Kentucky. Key deliverables include: (1) biweekly collection and laboratory analysis of retail meat samples (chicken breast, ground turkey, ground beef, pork, and seafood) from six geographically and socioeconomically diverse regions spanning urban areas (Lexington, Louisville, Northern Kentucky) and underserved rural and Appalachian communities (Hazard, Morehead, Paducah), with bacterial isolation of six target pathogens conducted per NARMS protocols and monthly shipment of confirmed isolates to the FDA Center for Veterinary Medicine; and (2) development and maintenance of a statewide database documenting antimicrobial resistance prevalence in retail meat products through antimicrobial susceptibility testing and whole-genome sequencing analysis, cataloging pathogen prevalence by commodity type and geographic region.Federal Cooperative Agreement Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $0 | 3/9/26 | ||
| Not listed | $200.0k | 9/19/25 | ||
| Not listed | $200.0k | 9/19/25 |